CDH1 and breast cancer: We analysed 17 metaplastic breast cancer samples that all scored negative or low for E-cadherin expression (scores 0 or 1) and found that all of them also scored low (score 1) for EP300 expression in the mesenchymal metaplastic component (Fig. 7b).